[Integrated molecular medicine for neuronal and neoplastic disorders]

Seikagaku. 2007 Feb;79(2):121-30.
[Article in Japanese]
No abstract available

Publication types

  • Review

MeSH terms

  • Animals
  • Benzoquinones / therapeutic use
  • Cytokines / physiology
  • Genetic Therapy
  • Glycogen Synthase Kinase 3 / physiology
  • Glycogen Synthase Kinase 3 beta
  • Gonadotropin-Releasing Hormone / antagonists & inhibitors
  • HSP90 Heat-Shock Proteins / antagonists & inhibitors
  • Humans
  • Intercellular Signaling Peptides and Proteins / physiology
  • Lactams, Macrocyclic / therapeutic use
  • Leuprolide / therapeutic use
  • Microfilament Proteins
  • Midkine
  • Muscular Disorders, Atrophic / genetics
  • Muscular Disorders, Atrophic / pathology
  • Muscular Disorders, Atrophic / therapy
  • Neoplasms / genetics*
  • Neoplasms / pathology
  • Neoplasms / therapy*
  • Nerve Tissue Proteins / physiology
  • Neurodegenerative Diseases / genetics*
  • Neurodegenerative Diseases / pathology
  • Neurodegenerative Diseases / therapy*
  • Phosphorylation
  • Signal Transduction
  • Vesicular Transport Proteins

Substances

  • Benzoquinones
  • CCDC88A protein, human
  • Cytokines
  • HSP90 Heat-Shock Proteins
  • Intercellular Signaling Peptides and Proteins
  • Lactams, Macrocyclic
  • Microfilament Proteins
  • Nerve Tissue Proteins
  • Vesicular Transport Proteins
  • collapsin response mediator protein-2
  • Midkine
  • Gonadotropin-Releasing Hormone
  • tanespimycin
  • Glycogen Synthase Kinase 3 beta
  • Glycogen Synthase Kinase 3
  • Leuprolide